EN
HI

Bafna Pharmaceuticals Share price

BAFNAPH

89.02

3.57 (4.18%)
NSE
BSE
Last updated on 15 Jul, 2025 | 15:31 IST
BUYSELL
Today's High

89.43

Today's Low

84.70

52 Week Low

69.00

52 Week High

94.99

The current prices are delayed, login to your account for live prices

Bafna Pharmaceuticals Chart

Bafna Pharmaceuticals Share Key Metrics

Volume
9922.00
Market Cap
210.59 CR
LTQ@LTP
300@89.02
ATP
87.5
Var Margin
25 %
Circuit Range
81.17-89.72
Delivery %
43.92 %
Value
8.68 L
ASM/GSM
No
Market Lot
1

Bafna Pharmaceuticals Futures & Options

Data Not Found

Bafna Pharmaceuticals Corporate Actions

DateAgenda
No Data Found
DateEvent TypeAgenda
No Data Found

Bafna Pharmaceuticals News

Bafna Pharmaceuticals Ltd Q2 net profits grow 89%

Nov 14 2021 14:15:35

In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticals

Nov 14 2021 17:15:23

In talks with multinational pharma cos for acquisition of brands: Bafna pharmaceuticals

Nov 14 2021 16:45:37
Read More

About Bafna Pharmaceuticals AboutThe

NSE : 17742  
BSE : 532989  
ISIN : INE878I01022  

Bafna was incorporated on March 28 1995 with the Registrar of Companies Tamilnadu and acquired the entire business of Bafna Pharmaceutical a proprietary concern of Mr. Bafna Mahaveer Chand.Bafna Pharmaceutical has been engaged in the business of manufacturing pharmaceutical formulations of Betalactam and Non Betalactam products. The first manufacturing unit was set up at Madhavaram during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a. Subsequently the capusule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990.Major events in the History of the Company:Year Event1981 Started as a Proprietorship concern1984 Set up its first manufacturing unit on 04.10.1984 at Madhavaram with tablet line of installed capacity of 420 Lacs p.a.1987 Added Capsules Line with installed capacity of 300 lacs p.a.1990 Added Liquid Line with installed capacity of 45000 ltr. p.a. Made its first supplies to Government of Tamilnadu1994 Started Contract Manufacturing activity for Crossland Laboratories WHO GMP Certification for Madhavarm Unit received Submitted Dossier for registration for 57 products in Srilanka Made its first export to Srilanka1995 Started Supply to ESI corporation.2003 Received Export House" Status by Ministry of Commerce & Industry2005 Best Supplier" Award by State Pharmaceuticals Corporation of Sri Lanka Started Construction of new plant at Grantlyon village Madhavaram Plant approved as per revised Schedule ?M? 2006 Registered 4 products in Ukraine. New plant at Grantlyon Inaugurated by Governor of Tamil Nadu on 02.10.2006. Received ISO 9001: 2000 certificate2007 Inspection by Ghana Inspectors in 2007 got accreditation. Rated as "SE2A" by Dun & Bradstreet Manufacturing Licence Received for Grantlyon Unit WHO GMP Certification for Grantlyon Unit

Bafna Pharmaceuticals Management

NamePosition
Mrs. S Hemalatha Whole Time Director
Mrs. Akila C Raju Non Exe.Non Ind.Director
Ms. R Chitra Ind. Non-Executive Director
Mr. B Kamlesh Kumar Ind. Non-Executive Director
Mr. P K Sundaresan Ind. Non-Executive Director
Read More

Bafna Pharmaceuticals FAQs

Bafna Pharmaceuticals शेयर का खरीद मूल्य 89.02 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Bafna Pharmaceuticals शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Bafna Pharmaceuticals शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Bafna Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Bafna Pharmaceuticals शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.14 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Bafna Pharmaceuticals का मार्केट कैप 210.59 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Bafna Pharmaceuticals शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 94.99 और 69.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।